Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| B cell | 11 studies | 18% ± 3% | |
| naive B cell | 10 studies | 19% ± 2% | |
| glutamatergic neuron | 4 studies | 20% ± 1% | |
| memory B cell | 3 studies | 16% ± 1% | |
| GABAergic neuron | 3 studies | 20% ± 1% | |
| oligodendrocyte precursor cell | 3 studies | 22% ± 4% | |
| oligodendrocyte | 3 studies | 19% ± 1% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 5 studies | 19% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 100% | 1082.51 | 459 / 459 | 99% | 17.12 | 1109 / 1118 |
| esophagus | 100% | 464.00 | 1444 / 1445 | 98% | 10.57 | 180 / 183 |
| ovary | 100% | 497.32 | 180 / 180 | 97% | 5.71 | 416 / 430 |
| brain | 98% | 334.04 | 2593 / 2642 | 99% | 9.54 | 695 / 705 |
| lung | 99% | 559.31 | 575 / 578 | 97% | 7.33 | 1118 / 1155 |
| thymus | 100% | 835.95 | 653 / 653 | 94% | 7.15 | 568 / 605 |
| stomach | 99% | 404.11 | 354 / 359 | 94% | 6.29 | 269 / 286 |
| prostate | 100% | 760.87 | 245 / 245 | 93% | 5.56 | 465 / 502 |
| bladder | 100% | 568.38 | 21 / 21 | 92% | 7.19 | 465 / 504 |
| intestine | 99% | 824.76 | 961 / 966 | 90% | 5.46 | 475 / 527 |
| uterus | 100% | 498.31 | 170 / 170 | 89% | 6.09 | 408 / 459 |
| kidney | 100% | 383.20 | 89 / 89 | 83% | 4.16 | 752 / 901 |
| pancreas | 94% | 260.98 | 309 / 328 | 87% | 4.79 | 155 / 178 |
| skin | 100% | 842.56 | 1806 / 1809 | 72% | 3.91 | 340 / 472 |
| adrenal gland | 100% | 1024.65 | 258 / 258 | 57% | 2.55 | 132 / 230 |
| liver | 78% | 166.28 | 176 / 226 | 33% | 1.43 | 135 / 406 |
| spleen | 100% | 1975.35 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 3.26 | 1 / 1 |
| adipose | 100% | 474.26 | 1198 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 98% | 346.79 | 1310 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 97% | 19.57 | 28 / 29 |
| heart | 90% | 228.01 | 778 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 84% | 3.95 | 38 / 45 |
| peripheral blood | 84% | 896.12 | 783 / 929 | 0% | 0 | 0 / 0 |
| muscle | 57% | 96.68 | 455 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 14% | 0.37 | 11 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0008150 | Biological process | biological_process |
| GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0005575 | Cellular component | cellular_component |
| GO_0005634 | Cellular component | nucleus |
| GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
| GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
| GO_0005515 | Molecular function | protein binding |
| GO_0046872 | Molecular function | metal ion binding |
| GO_0003674 | Molecular function | molecular_function |
| Gene name | ZNF107 |
| Protein name | Zinc finger protein 107 (Zinc finger protein 588, isoform CRA_c) Zinc finger protein 107 Zinc finger protein 107 (Zinc finger protein 588) (Zinc finger protein ZFD25) ZNF107 protein |
| Synonyms | hCG_41164 ZFD25 ZNF588 |
| Description | FUNCTION: May be involved in transcriptional regulation. |
| Accessions | Q8WVL4 A0A8C8KK49 ENST00000395391.2 A0A087WYK5 ENST00000360117.8 Q9UII5 A0A0B4J2G0 ENST00000620827.6 ENST00000613690.5 ENST00000344930.7 ENST00000423627.6 C9JSF9 |